David Stepensky
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 5
- Lipid Membrane Structure and Behavior 5
- Oncology 15
- Drug Transport and Resistance Mechanisms 7
- Bone health and treatments 6
- Co-authors
- L. N. Kozlovskaya (4 shared papers)Amit Ranjan Maity (6 shared papers)Amnon Hoffman (9 shared papers)Michael Friedman (6 shared papers)Amnon Hoffman (4 shared papers)Itamar Raz (3 shared papers)Abraham J. Domb (2 shared papers)Eran Lavy (4 shared papers)
- Journals
- International Journal of Pharmaceutics (8 papers)Journal of Controlled Release (6 papers)Pharmaceutical Research (4 papers)Clinical Pharmacokinetics (3 papers)Journal of Pharmaceutical Sciences (3 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
David Stepensky
65 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 138
- Pharmaceutical Science 547
- Biomaterials 403
- Molecular Medicine 76
- Molecular Biology 814
- Oncology 268
Countries citing papers authored by David Stepensky
This map shows the geographic impact of David Stepensky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Stepensky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Stepensky more than expected).
Fields of papers citing papers by David Stepensky
This network shows the impact of papers produced by David Stepensky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Stepensky. The network helps show where David Stepensky may publish in the future.
Co-authors
The 25 scholars most cited alongside David Stepensky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 294 | |
| 2 | 2004 | 171 | |
| 3 | 2016 | 127 | |
| 4 | 2001 | 115 | |
| 5 | 2002 | 108 | |
| 6 | 2011 | 107 | |
| 7 | 2004 | 103 | |
| 8 | 2000 | 88 | |
| 9 | 2010 | 76 | |
| 10 | 2002 | 63 | |
| 11 | 1999 | 60 | |
| 12 | 2003 | 57 | |
| 13 | 2003 | 49 | |
| 14 | 2015 | 46 | |
| 15 | 2012 | 45 | |
| 16 | 2021 | 43 | |
| 17 | 2013 | 42 | |
| 18 | 2013 | 40 | |
| 19 | 2016 | 40 | |
| 20 | 2019 | 39 |
About David Stepensky
David Stepensky is a scholar working on Molecular Biology, Oncology, Biomaterials, Pharmaceutical Science and Pharmacology, having authored 66 papers that have together received 2.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (11 papers), Drug Transport and Resistance Mechanisms (7 papers), Bone health and treatments (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bone health and osteoporosis research (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Lipid Membrane Structure and Behavior (5 papers). The work is most often cited by research in Pharmaceutical Science (547 citations), Biomaterials (403 citations), Molecular Medicine (76 citations), Molecular Biology (814 citations) and Oncology (268 citations). David Stepensky has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include L. N. Kozlovskaya, Amit Ranjan Maity, Amnon Hoffman, Michael Friedman, Amnon Hoffman, Itamar Raz, Abraham J. Domb, Eran Lavy, Eytan A. Klausner and Joseph Frucht‐Pery. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Pharmaceutical Research, Clinical Pharmacokinetics and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.